| Emily Christine Herndon, DPT | |
|
200 Hubbard St, Plains, MT 59859 | |
| (406) 531-5395 | |
| Not Available |
| Full Name | Emily Christine Herndon |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 18 Years |
| Location | 200 Hubbard St, Plains, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215025861 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 33130 (California) | Secondary |
| 225100000X | Physical Therapist | 2123 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Plains Physical Therapy Pc | 8022178292 | 7 |
News Archive
Researchers at The Saban Research Institute of Children's Hospital Los Angeles (CHLA) have demonstrated that targeting survivin - a protein that inhibits apoptosis or cell death - enhances the effectiveness of chemotherapy in cells and mouse models of retinoblastoma (Rb), the most common malignant tumor of the eye in children.
Trypanosomes are single-celled parasites that cause diseases such as human African sleeping sickness and Nagana in animals. But they are also used in basic research as a model system to study fundamental biological questions.
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.
A major effort to conduct research on women's health began about 20 years ago, when it became clear that results from studies until then, which involved mostly male subjects, were often misinterpreted or misapplied in the cases of female patients. Women's Health Research: Progress, Promise, and Pitfalls, new from the Institute of Medicine, offers a progress report on the state of women's health research.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 1 days ago
| Provider Name | Plains Physical Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235389909 PECOS PAC ID: 8022178292 Enrollment ID: O20081118000220 |
News Archive
Researchers at The Saban Research Institute of Children's Hospital Los Angeles (CHLA) have demonstrated that targeting survivin - a protein that inhibits apoptosis or cell death - enhances the effectiveness of chemotherapy in cells and mouse models of retinoblastoma (Rb), the most common malignant tumor of the eye in children.
Trypanosomes are single-celled parasites that cause diseases such as human African sleeping sickness and Nagana in animals. But they are also used in basic research as a model system to study fundamental biological questions.
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.
A major effort to conduct research on women's health began about 20 years ago, when it became clear that results from studies until then, which involved mostly male subjects, were often misinterpreted or misapplied in the cases of female patients. Women's Health Research: Progress, Promise, and Pitfalls, new from the Institute of Medicine, offers a progress report on the state of women's health research.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Christine Herndon, DPT Po Box 190, Plains, MT 59859-0190 Ph: (406) 826-4383 | Emily Christine Herndon, DPT 200 Hubbard St, Plains, MT 59859 Ph: (406) 531-5395 |
News Archive
Researchers at The Saban Research Institute of Children's Hospital Los Angeles (CHLA) have demonstrated that targeting survivin - a protein that inhibits apoptosis or cell death - enhances the effectiveness of chemotherapy in cells and mouse models of retinoblastoma (Rb), the most common malignant tumor of the eye in children.
Trypanosomes are single-celled parasites that cause diseases such as human African sleeping sickness and Nagana in animals. But they are also used in basic research as a model system to study fundamental biological questions.
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.
A major effort to conduct research on women's health began about 20 years ago, when it became clear that results from studies until then, which involved mostly male subjects, were often misinterpreted or misapplied in the cases of female patients. Women's Health Research: Progress, Promise, and Pitfalls, new from the Institute of Medicine, offers a progress report on the state of women's health research.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 1 days ago
Curt Hammill, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 Fax: 406-826-4384 | |
Ross Eckstein, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 | |
Stuart Meints, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 | |
Dr. Noah M Bray, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 200 South Hubbard St, Plains, MT 59859 Phone: 406-826-4384 | |
Mrs. Nicole Lynn Feliksa, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 Fax: 406-826-4394 |